View
239
Download
1
Category
Preview:
Citation preview
8/18/2019 Kuliah Reaksi Hipersensivitas & Auto Imun
1/27
REAKSIH IPERSEN SIVITAS &
AU TO IM U N
dr.HOTMEN SIJABAT, SpPD
8/18/2019 Kuliah Reaksi Hipersensivitas & Auto Imun
2/27
Sistem Imun Terdiri atas sistem imun nonspesifk(natural/innate) dan sistem imunspesifk (adaptive/acquires) Komponen sistem imun nonspesifk : Fisik
(kulit,selaput lendir), larut (lisozim, asamlambung) selular (M, !M, k)
Komponen sistem imun spesifk :"umoral, seluler
8/18/2019 Kuliah Reaksi Hipersensivitas & Auto Imun
3/27
Sistem im un spesifik
Kemampuan untuk mengenalbenda (antigen) #ang dianggap
asing bagi dirin#a "an#a dapat men#ingkirkan
benda asing #ang suda$
dikenal sebelumn#a %istem imun spesifk $umoral
%istem imun spesifk selular
8/18/2019 Kuliah Reaksi Hipersensivitas & Auto Imun
4/27
&im'osit sal dari Multipoten, sumsum tulang *i'erensiasi dalam sumsum tulang
enda asing akan merangsang sel akanberdi'erensiasi dan proli'erasimembentuk antibodi Membentuk antibodi dilepas ke dalam serum
Fungsi antibodi perta$anan ter$adap in'eksiekstraselular, virus , bakteri dan menetralisirtoksin
Memori ter$adap perta$anan #angdi$asilkan berta$an lama
8/18/2019 Kuliah Reaksi Hipersensivitas & Auto Imun
5/27
Antibodi
Antibodi =immunoglobulins (+g)
+naktivasi antigen
dengan cara Fiksasi komplemen etralisasi glutinasi !resipitasi
amma globulin : +g-.0, +g-120, +gM-30,+g*-10, and +g4-565570
+g dapat mela8atisa8ar dara$ plasenta
8/18/2019 Kuliah Reaksi Hipersensivitas & Auto Imun
6/27
Reaksi hipersensivitas
Klasifkasi menurut ell dan9oomb
Tipe + eaksi $ipersensivitas cepat +g4, T$7, selmast, eosinofl
Tipe 76 antibodi ter$adap sel +gM, +g ter$adap permukaan sel atau antigen
matriks ekstraselular
Tipe ;6 Kompleks antibodi dan antigen
Kompl imun #ang terdiri atas antigen dalamsirkulasi dan +gM atau +g; #ang diendapkandalam membran basal vaskuler
Tipe
8/18/2019 Kuliah Reaksi Hipersensivitas & Auto Imun
7/27
Reaksi tipe I
= anaflaksis atau reaksi alergintigen #g masuk ditangkap 'agosit>T$7>sitokin>sel >+g46+g4 diikat ole$ reseptor +g* #g dimilikisel basofl, mast, eosinofl
+la antigen #g sama mema?an,
antigen diikat +g4 pada permukaan selmast #g menimbulkan degranulasi selmast dan mengeluarkan mediator$istamin, prostagalandin, leukotrin
sma bronkial, urtikaria, *
8/18/2019 Kuliah Reaksi Hipersensivitas & Auto Imun
8/27
+nduction and e@ector mec$anisms in t#pe 1 $#persensitivi
8/18/2019 Kuliah Reaksi Hipersensivitas & Auto Imun
9/27
Hipersensivitas tipe 2
eaksi $ipersensivitas sitotoksik *apat mengenai berbagai ?aringan dan
organ
ntigen biasan#a endogen, $apten(eksogen) dapat menempel pada membransel $ipersensitivitas tipe 7
eaksi dapat berlangsung dalam $itungan
menit sampai ?am Mediator reaksi adala$ +gM atau +g akan
mengakti'kan reseptor FcA-,
%el K akan berperan sebagai e'ektor dan
menimbulkan kerusakan melalui ntibod#
8/18/2019 Kuliah Reaksi Hipersensivitas & Auto Imun
10/27
Skem a reaksi tipe II
8/18/2019 Kuliah Reaksi Hipersensivitas & Auto Imun
11/27
Tpe II !persensiti"it. T#pe ++ responses are mediated b# immunoglobulin (+g)directed against cell sur'ace or matri= antigens, 8$ic$ initiates e@ector responses t$roug$ t$eFc receptor 'or +g (FcA) and complement6 T$e relative contributions o' t$ese pat$8a#s var#8it$ t$e +g subclass and t$e nature o' t$e antigen6 Bnl# FcA-mediated p$agoc#tosis b#macrop$ages (MC) is depicted in t$is 'igure6 ctivation o' complement components 8ould
result in binding o' 9;b to t$e red blood cell membrane, rendering red blood cells susceptibleto p$agoc#tosis and leading to 'ormation o' t$e membrane attack comple= and cell l#sis
8/18/2019 Kuliah Reaksi Hipersensivitas & Auto Imun
12/27
Mekanisme Reaksi HS Tipe III:
antigen masuk ke dalam dara$ (kapiler)
terbentukkompleks antigen dan antibodi dengan rasio 2 antigenterikat dengan 1 IgG atau IgA (monomeric yang soluble) menempel di endotel kapiler (terutama di gin?al dan
paru atau terba8a ke daera$-daera$ dengan aliran
dara$ #ang turbulen)
men#ebabkan inDamasi mengakti'kan sistem komplemen mengakti'kan9;a, 9
8/18/2019 Kuliah Reaksi Hipersensivitas & Auto Imun
13/27
PEN YAKIT KO M PLEKS IM U N :Sebab, Antigen dan Tem patM engendap
Sebab Antigen Tempat
KompleksMengendap
Infeksi persisten Antigen Mikroba Organ yangdiinfeksi, ginjal
Auto imunitas Antigen sendiri Ginjal, sendi,
pembuluh darah,
kulit
Ekstrinsik Antigen lingkungan Paru
8/18/2019 Kuliah Reaksi Hipersensivitas & Auto Imun
14/27
TYPE III HYPERSENSITIVITY
Penicillin
Sulfonamid
8/18/2019 Kuliah Reaksi Hipersensivitas & Auto Imun
15/27
Mekanisme Reaksi HS Tipe IV :
+munopatologi diperantarai ole$ T cell danmelibatkan dela# $#persensitivit#
gE !9(sel &anger$ans, kup'er, dendritik)> dikenali sel lim'osit (butu$ memori T cell
spesifk t$d g ) > sensitisasi sel >melepaskan mediator inDamasi
8/18/2019 Kuliah Reaksi Hipersensivitas & Auto Imun
16/27
TYPE IV HYPERSENSITIVITY
8/18/2019 Kuliah Reaksi Hipersensivitas & Auto Imun
17/27
Tpe I# !persensiti"it. T#pe + responses are mediated b# T cells t$roug$ t$ree di@erentpat$8a#s6 +n t$e frst, t#pe 1 $elper T (T"1) cells recognize soluble antigens and releaseinter'eron-A (+F-A) to activate e''ector cells, in t$is case macrop$ages (MG), and cause tissuein?ur#6 +n T"7-mediated responses, eosinop$ils predominate6 T"7 cells produce c#tokines to
recruit and activate eosinop$ils, leading to t$eir degranulation and tissue in?ur# l#mp$oc#tes(9T&s)6 +n t$e t$ird pat$8a#, damage is caused directl# b# c#tol#tic T6 +&, interleukin
8/18/2019 Kuliah Reaksi Hipersensivitas & Auto Imun
18/27
8/18/2019 Kuliah Reaksi Hipersensivitas & Auto Imun
19/27
Autim m une di!"de"!
n autoimmune disorder isa condition t$at occurs
8$en t$e immune s#stemmistakenl# attacks anddestro#s $ealt$# bod#
tissue6 T$ere are more t$an 35
di@erent t#pes o'
autoimmune disorders6
8/18/2019 Kuliah Reaksi Hipersensivitas & Auto Imun
20/27
+n patients 8it$ an autoimmune
disorder, t$e immune s#stemcanHt tell t$e di@erence bet8een$ealt$# bod# tissue and antigens
T$e result is an immune responset$at destro#s normal bod# tissues6
T$is response is a$#persensitivit# reaction similar tot$e response in allergic conditions6
http://www.nlm.nih.gov/medlineplus/ency/article/000821.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/000812.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/000812.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/000821.htm
8/18/2019 Kuliah Reaksi Hipersensivitas & Auto Imun
21/27
J$at causes t$e immunes#stem to no longer tell t$e
di@erence bet8een $ealt$#bod# tissues and antigens isunkno8n
n autoimmune disorder ma#result in: T$e destruction o' one or more
t#pes o' bod# tissue
bnormal gro8t$ o' an organ
9$anges in organ 'unction
8/18/2019 Kuliah Reaksi Hipersensivitas & Auto Imun
22/27
n autoimmune disorder ma# a@ectone or more organ or tissue t#pes6
Brgans and tissues commonl# a@ectedb# autoimmune disorders include:
lood vessels
9onnective tissues 4ndocrine glands suc$ as t$e
t$#roid or pancreas
oints Muscles
ed blood cells
%kin
http://www.nlm.nih.gov/medlineplus/ency/article/002351.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/002351.htm
8/18/2019 Kuliah Reaksi Hipersensivitas & Auto Imun
23/27
person ma# $ave more t$an one autoimmunedisorder at t$e same time6 4=amples o' autoimmune(or autoimmune-related) disorders include:
ddisonHs disease
9eliac disease - sprue (gluten-sensitive enteropat$#)
*ermatom#ositis
raves disease
"as$imotoHs t$#roiditis
Multiple sclerosis
M#ast$enia gravis
!ernicious anemia
eactive art$ritis
$eumatoid art$ritis %?ogren s#ndrome
%#stemic lupus er#t$ematosus
T#pe + diabetes
http://www.nlm.nih.gov/medlineplus/ency/article/000378.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/000233.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/000233.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/000839.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/000358.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/000371.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/000737.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/000712.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/000569.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/000440.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/000431.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/000456.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/000435.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/000305.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/000305.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/000435.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/000435.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/000456.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/000456.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/000431.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/000440.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/000569.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/000712.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/000737.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/000371.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/000371.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/000358.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/000839.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/000233.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/000233.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/000378.htm
8/18/2019 Kuliah Reaksi Hipersensivitas & Auto Imun
24/27
%#mptoms o' an autoimmune
disease var# based on t$e diseaseand location o' t$e abnormalimmune response6
%#mptoms t$at o'ten occur8it$ autoimmune diseasesinclude:
Fatigue Fever
eneral ill-'eeling (malaise)
http://www.nlm.nih.gov/medlineplus/ency/article/003088.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003089.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003089.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003088.htm
8/18/2019 Kuliah Reaksi Hipersensivitas & Auto Imun
25/27
%igns depend on t$e t#pe o'disease6
Tests t$at ma# be done todiagnose an autoimmune disorderma# include: ntinuclear antibod# tests
utoantibod# tests
99
9-reactive protein (9!)
4r#t$roc#te sedimentation rate (4%)
http://www.nlm.nih.gov/medlineplus/ency/article/003642.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003356.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003638.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003638.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003356.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003642.htm
8/18/2019 Kuliah Reaksi Hipersensivitas & Auto Imun
26/27
T$e goals o' treatment are to:
educe s#mptoms 9ontrol t$e autoimmune process
Maintain t$e bod#Hs abilit# to
fg$t disease
J$ic$ treatments are used
depends on t$e specifcdisease and #our s#mptoms6
8/18/2019 Kuliah Reaksi Hipersensivitas & Auto Imun
27/27
Medicines are o'ten prescribedto control or reduce t$eimmune s#stemHs response6
T$e# are o'ten calledimmunosuppressivemedicines6
%uc$ medicines ma# include
corticosteroids (suc$ asprednisone) and nonsteroiddrugs suc$ as azat$ioprine,
c#clop$osp$amide
Recommended